Skip to main content

Advertisement

Table 3 The element and extent of information that research participants wanted to receive

From: What information and the extent of information research participants need in informed consent forms: a multi-country survey

Element Abbreviation n Extent of information
Mean SE SD Median IQR
1. General items
 1.1 Title of research Title (n = 2100) 4.33 0.021 0.941 5 (4–5)
 1.2 Name of researchers Name (n = 2091) 4.08 0.024 1.088 4 (4–5)
 1.3 Affiliation or organization of researchers Affil (n = 2083) 4.10 0.023 1.035 4 (4–5)
 1.4 Recognition that this is research Resea (n = 2095) 4.29 0.021 0.963 5 (4–5)
 1.5 Contact information regarding the research study cInfo (n = 2040) 4.29 0.020 0.899 5 (4–5)
 1.6 Contact information about the participant’s right cInfoR (n = 2035) 4.26 0.021 0.932 5 (4–5)
 1.7 Source of funds and sponsors Spons (n = 2082) 3.75 0.027 1.233 4 (3–5)
 1.8 Conflict of interest Coi (n = 2020) 3.79 0.027 1.228 4 (3–5)
2. Study-specific items
 2.1 Background and rationale of research Backg (n = 2084) 4.16 0.021 0.966 4 (4–5)
 2.2 Purpose of research Purp (n = 2093) 4.35 0.019 0.868 5 (4–5)
 2.3 Eligibility of the participant Eligib (n = 2104) 4.28 0.020 0.915 5 (4–5)
 2.4 Study design of research Desig (n = 2078) 3.96 0.023 1.071 4 (3–5)
 2.5 Interventions under investigation Interv (n = 2080) 4.37 0.020 0.895 5 (4–5)
 2.6 Common adverse effects of the intervention coAE (n = 2082) 4.45 0.019 0.857 5 (4–5)
 2.7 All possible adverse effects of the intervention allAE (n = 2086) 4.36 0.020 0.933 5 (4–5)
 2.8 Other options or alternative treatments Altern (n = 2088) 4.02 0.024 1.093 4 (3–5)
 2.9 Duration of the participant’s participation Durat (n = 2069) 4.17 0.021 0.971 4 (4–5)
 2.10 Schedule and procedure Proc (n = 2089) 4.29 0.020 0.894 5 (4–5)
 2.11 Identification of any experimental procedures eProc (n = 2075) 4.11 0.022 1.013 4 (4–5)
 2.12 Number of participants involved Numb (n = 2092) 3.58 0.027 1.218 4 (3–5)
 2.13 Criteria for termination Term (n = 2045) 4.23 0.022 0.975 4 (4–5)
3. Items related to the subject’s right
 3.1 Voluntary participation Volun (n = 2093) 4.19 0.022 1.014 4 (4–5)
 3.2 Consequence of withdrawal cWith (n = 2039) 4.04 0.024 1.097 4 (4–5)
 3.3 Right to receive new information nInfo (n = 2048) 4.25 0.020 0.927 4 (4–5)
4. Items related to risk-benefit
 4.1 Major foreseeable risk mjRis (n = 2077) 4.47 0.020 0.902 5 (4–5)
 4.2 Minor foreseeable risk miRis (n = 2077) 4.25 0.021 0.968 5 (4–5)
 4.3 Possibly unforeseeable risk ufRis (n = 2043) 4.27 0.024 1.064 5 (4–5)
 4.4 Direct health benefit dBene (n = 2088) 4.47 0.017 0.793 5 (4–5)
 4.5 Indirect benefit iBene (n = 2096) 4.31 0.019 0.865 5 (4–5)
 4.6 Societal benefit sBene (n = 2049) 4.30 0.020 0.901 5 (4–5)
 4.7 Post-trial benefit or provision pBene (n = 2048) 4.23 0.021 0.950 4 (4–5)
5. Items related to data and sample storage
 5.1 Confidentiality and the limit of confidentiality Confi (n = 2048) 4.29 0.022 0.984 5 (4–5)
 5.2 Storage of human material Stora (n = 2041) 3.97 0.025 1.148 4 (3–5)
 5.3 Reuse of human material Reuse (n = 2043) 4.04 0.025 1.113 4 (4–5)
6. Items related to monetary issues
 6.1 Payment and/or remuneration Paym (n = 2040) 3.85 0.026 1.156 4 (3–5)
 6.2 Anticipated expense Expen (n = 2025) 4.00 0.024 1.099 4 (4–5)
 6.3 Compensation for injury Compe (n = 2038) 4.32 0.020 0.912 5 (4–5)
  1. IQR interquartile range, SD standard deviation, SE standard error of the mean